Changes in survival among people with AIDS in Lazio, Italy from 1993 to 1998

被引:28
作者
Porta, D
Rapiti, E
Forastiere, F
Pezzotti, P
Perucci, CA
机构
[1] Epidemiol Dept Lazio Reg, I-00198 Rome, Italy
[2] Ist Super Sanita, Cent Operativo AIDS, I-00161 Rome, Italy
关键词
AIDS; longitudinal study; mortality; surveillance; survival;
D O I
10.1097/00002030-199910220-00016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: To investigate temporal changes in survival of persons with AIDS (PWA) diagnosed in Lazio, Italy. Design: Longitudinal study of 2862 PWA registered at the AIDS Surveillance System in the period 1 January 1993 to 30 June 1997 and followed for vital status up to 31 May 1998. Methods: Hazard ratios (HR) of death were calculated by year of diagnosis and by year of follow-up, adjusting for gender, age, modality of exposure, CD4 cell count at diagnosis, and AIDS-defining illness, using the Cox proportional regression model. Results: in the period 1 January 1993 to 31 May 1998, 1914 PWA died. The multivariate model showed a decrease of the risk of death for patients diagnosed from 1995 onward compared with patients diagnosed in 1993 [1995: HR 0.82; 95% confidence intervals (CI) 0.73-0.93; 1996: HR 0.44; 95% CI 0.38-0.51; first semester of 1997: HR 0.47; 95% CI 0.37-0.59]. The model with the year of followup modeled as time-dependent variable showed a statistically significant decline in the risk of death starting from the first quarter of 1997 (HR 0.62; 95% CI 0.48-0.80) and reached the minimum in the first two quarters of 1998 (first quarter: HR 0.13; 95% CI 0.08-0.21; second quarter: HR 0.14, 95% CI 0.08-0.25). There was a small difference in the magnitude of the risk estimates among genders, with a slower improvement in survival among females [first semester of 1997 for males HR was 0.51 (95% CI 0.39-0.66) whereas for females HR was 0.80 (95% Ct 0.51-1.27)]. Conclusions: Survival of PWA in a population-based study improved significantly in the era when highly active antiretroviral therapy became available, but such improvement is not homogeneous among genders. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:2125 / 2131
页数:7
相关论文
共 14 条
[1]   Effect of gender, age, transmission category, and antiretroviral therapy on the progression of human immunodeficiency virus infection using multistate Markov models [J].
Alioum, A ;
Leroy, V ;
Commenges, D ;
Dabis, F ;
Salamon, R .
EPIDEMIOLOGY, 1998, 9 (06) :605-612
[2]   TRENDS IN SURVIVAL AMONG PERSONS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME IN NEW-YORK-CITY - THE EXPERIENCE OF THE FIRST DECADE OF THE EPIDEMIC [J].
BLUM, S ;
SINGH, TP ;
GIBBONS, J ;
FORDYCE, EJ ;
LESSNER, L ;
CHIASSON, MA ;
WEISFUSE, IB ;
THOMAS, PA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (04) :351-361
[3]   RACE, SEX, DRUG-USE, AND PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE [J].
CHAISSON, RE ;
KERULY, JC ;
MOORE, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (12) :751-756
[4]   Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study [J].
Egger, M ;
Hirschel, B ;
Francioli, P ;
Sudre, P ;
Wirz, M ;
Flepp, M ;
Rickenbach, M ;
Malinverni, R ;
Vernazza, P ;
Battegay, M ;
Bernasconi, E ;
Burgisser, P ;
Erb, P ;
Fierz, W ;
Grob, P ;
Gruninger, U ;
Jeannerod, L ;
Ledergerber, B ;
Luthy, R ;
Matter, L ;
Opravil, M ;
Paccaud, F ;
Perrin, L ;
Pichler, W ;
Piffaretti, GC ;
Rutschmann, O ;
Zanetti, G .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7117) :1194-1199
[5]   A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J].
Hammer, SM ;
Squires, KE ;
Hughes, MD ;
Grimes, JM ;
Demeter, LM ;
Currier, JS ;
Eron, JJ ;
Feinberg, JE ;
Balfour, HH ;
Dayton, LR ;
Chodakewitz, JA ;
Fischl, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :725-733
[6]  
HELLINGER FJ, 1993, HEALTH SERV RES, V28, P543
[7]   Improved survival among HIV-infected individuals following initiation of antiretroviral therapy [J].
Hogg, RS ;
Heath, KV ;
Yip, B ;
Craib, KJP ;
O'Shaughnessy, MV ;
Schechter, MT ;
Montaner, JSG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06) :450-454
[8]  
LAGORIO S, 1987, EPIDEMIOL PREV, V31, P57
[9]   SURVIVAL AND DISEASE PROGRESSION ACCORDING TO GENDER OF PATIENTS WITH HIV-INFECTION - THE TERRY-BEIRN-COMMUNITY-PROGRAMS FOR CLINICAL RESEARCH ON AIDS [J].
MELNICK, SL ;
SHERER, R ;
LOUIS, TA ;
HILLMAN, D ;
RODRIGUEZ, EM ;
LACKMAN, C ;
CAPPS, L ;
BROWN, LS ;
CARLYN, M ;
KORVICK, JA ;
DEYTON, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (24) :1915-1921
[10]   Changing patterns of mortality across Europe in patients infected with HIV-1 [J].
Mocroft, A ;
Vella, S ;
Benfield, TL ;
Chiesi, A ;
Miller, V ;
Gargalianos, P ;
Monforte, AD ;
Yust, I ;
Bruun, JN ;
Phillips, AN ;
Lundgren, JD .
LANCET, 1998, 352 (9142) :1725-1730